CeriBell PE Ratio 1970-1969 | CBLL
Current and historical p/e ratio for CeriBell (CBLL) from 1970 to 1969. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CeriBell PE ratio as of October 25, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
CeriBell PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-10-24 | 26.43 | inf |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.894B | $0.000B |
CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $198.731B | 25.27 |
Stryker (SYK) | United States | $134.451B | 31.42 |
Boston Scientific (BSX) | United States | $124.776B | 35.90 |
Medtronic (MDT) | Ireland | $116.179B | 17.29 |
EssilorLuxottica (ESLOY) | France | $108.009B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $46.167B | 0.00 |
Haleon (HLN) | United Kingdom | $44.588B | 32.83 |
ResMed (RMD) | United States | $37.582B | 30.89 |
Koninklijke Philips (PHG) | Netherlands | $29.768B | 22.62 |
Terumo (TRUMY) | Japan | $28.517B | 0.00 |
Zimmer Biomet Holdings (ZBH) | United States | $20.844B | 13.12 |
Baxter (BAX) | United States | $18.351B | 12.45 |
Insulet (PODD) | United States | $16.381B | 68.92 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.925B | 29.57 |
Demant (WILYY) | Denmark | $8.516B | 0.00 |
BellRing Brands (BRBR) | United States | $8.334B | 35.24 |
Lantheus Holdings (LNTH) | United States | $7.658B | 18.38 |
ICU Medical (ICUI) | United States | $4.288B | 40.92 |
Haemonetics (HAE) | United States | $3.867B | 19.13 |
Prestige Consumer Healthcare (PBH) | United States | $3.620B | 18.03 |
TG Therapeutics (TGTX) | United States | $3.617B | 38.29 |
Perrigo (PRGO) | Ireland | $3.423B | 10.81 |
Envista Holdings (NVST) | United States | $3.248B | 17.33 |
Neogen (NEOG) | United States | $2.993B | 34.53 |
GN Store Nord (GNNDY) | Denmark | $2.930B | 17.65 |
QuidelOrtho (QDEL) | United States | $2.601B | 16.39 |
Agios Pharmaceuticals (AGIO) | United States | $2.565B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.328B | 39.29 |
Curaleaf Holdings (CURLF) | Canada | $2.216B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.924B | 51.28 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.771B | 0.00 |
Warby Parker (WRBY) | United States | $1.723B | 0.00 |
InMode (INMD) | Israel | $1.474B | 9.39 |
AdaptHealth (AHCO) | United States | $1.432B | 10.34 |
AtriCure (ATRC) | United States | $1.360B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.278B | 0.00 |
Evolus (EOLS) | United States | $1.039B | 0.00 |
Owens & Minor (OMI) | United States | $1.034B | 7.98 |
BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.989B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.949B | 19.69 |
PetIQ (PETQ) | United States | $0.926B | 23.47 |
Cresco Labs (CRLBF) | United States | $0.796B | 0.00 |
National Vision Holdings (EYE) | United States | $0.770B | 24.48 |
Surmodics (SRDX) | United States | $0.536B | 113.91 |
VAREX IMAGING (VREX) | United States | $0.528B | 15.94 |
Canopy Growth (CGC) | Canada | $0.511B | 0.00 |
Valneva SE (VALN) | France | $0.483B | 0.00 |
Quanterix (QTRX) | United States | $0.479B | 0.00 |
ZimVie (ZIMV) | United States | $0.382B | 35.56 |
Viemed Healthcare (VMD) | United States | $0.359B | 38.50 |
Jin Medical (ZJYL) | China | $0.338B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.336B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.325B | 0.00 |
Cerus (CERS) | United States | $0.309B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.301B | 7.75 |
Zynex (ZYXI) | United States | $0.290B | 60.80 |
Biote (BTMD) | United States | $0.278B | 12.82 |
Sanara MedTech (SMTI) | United States | $0.277B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.276B | 0.00 |
High Tide (HITI) | Canada | $0.243B | 100.67 |
Omeros (OMER) | United States | $0.243B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.223B | 14.81 |
MacroGenics (MGNX) | United States | $0.219B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
Brainsway (BWAY) | Israel | $0.161B | 193.00 |
FitLife Brands (FTLF) | United States | $0.146B | 19.70 |
Veru (VERU) | United States | $0.122B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.119B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.117B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.116B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 23.65 |
Fonar (FONR) | United States | $0.096B | 9.95 |
Zevia PBC (ZVIA) | United States | $0.082B | 0.00 |
InterCure (INCR) | Israel | $0.077B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
Modular Medical (MODD) | United States | $0.072B | 0.00 |
Safety Shot (SHOT) | United States | $0.065B | 0.00 |
MariMed (MRMD) | United States | $0.063B | 0.00 |
Sanuwave Health (SNWVD) | United States | $0.062B | 1.58 |
Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.049B | 0.00 |
Exagen (XGN) | United States | $0.047B | 0.00 |
Apyx Medical (APYX) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.025B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
Nephros (NEPH) | United States | $0.015B | 0.00 |
GlucoTrack (GCTK) | United States | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.008B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 18.47 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |